HEADER NEUROPEPTIDE 09-JUN-03 1PLW TITLE NMR STRUCTURE OF METHIONINE-ENKEPHALIN IN FAST TUMBLING DMPC/DHPC TITLE 2 BICELLES COMPND MOL_ID: 1; COMPND 2 MOLECULE: MET-ENKEPHALIN 1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPETIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 4 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN) KEYWDS NEUROPEPTIDE EXPDTA SOLUTION NMR NUMMDL 80 AUTHOR I.MARCOTTE,F.SEPAROVIC,M.AUGER,S.M.GAGNE REVDAT 4 22-MAY-24 1PLW 1 REMARK REVDAT 3 23-FEB-22 1PLW 1 REMARK REVDAT 2 24-FEB-09 1PLW 1 VERSN REVDAT 1 16-MAR-04 1PLW 0 JRNL AUTH I.MARCOTTE,F.SEPAROVIC,M.AUGER,S.M.GAGNE JRNL TITL A MULTIDIMENSIONAL (1)H NMR INVESTIGATION OF THE JRNL TITL 2 CONFORMATION OF METHIONINE-ENKEPHALIN IN FAST-TUMBLING JRNL TITL 3 BICELLES. JRNL REF BIOPHYS.J. V. 86 1587 2004 JRNL REFN ISSN 0006-3495 JRNL PMID 14990485 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR 6.1C, CNS 1.1 REMARK 3 AUTHORS : VARIAN INC. (VNMR), AXEL T. BRUNGER (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE STRUCTURES ARE BASED ON A TOTAL OF 2 PHI ANGLE AND 57 NOE- REMARK 3 DERIVED DISTANCE CONSTRAINTS. REMARK 3 1000 HIGH-TEMPERATURE STEPS WERE USED (15 PS) UP TO A FINAL REMARK 3 TEMPERATURE OF 50000 K THEN 1000 COOLING STEPS (250 K, 15 PS) WERE REMARK 3 APPLIED. REMARK 3 FINALLY, 10 CYCLES OF 200 MINIMIZATION STEPS WERE PERFORMED. REMARK 3 A REPEL CONSTANT VALUE OF 0.8 WAS USED REMARK 4 REMARK 4 1PLW COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUN-03. REMARK 100 THE DEPOSITION ID IS D_1000019412. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 295 REMARK 210 PH : 4.5 REMARK 210 IONIC STRENGTH : 9MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 5.4UM MENK; DMPC/DHPC: 0.5:1 REMARK 210 (MOLAR RATIO); LIPID/PEPTIDE: 25: REMARK 210 1 (MOLAR RATIO); 10% W/V OF REMARK 210 LIPIDS IN WATER; 90%H2O, 10%D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; G-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 2.0 REV 2001.117.12.48, REMARK 210 NMRVIEW 5.0.4, CNS 1.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 80 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: PFG EXPERIMENTS WERE ALSO PERFORMED ON THE SAMPLE REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PLX RELATED DB: PDB REMARK 900 THE SAME PEPTIDE IN FAST TUMBLING BICELLES/DMPG DBREF 1PLW A 1 5 UNP P01210 PENK_HUMAN 100 104 SEQRES 1 A 5 TYR GLY GLY PHE MET CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 ENDMDL MODEL 2 ENDMDL MODEL 3 ENDMDL MODEL 4 ENDMDL MODEL 5 ENDMDL MODEL 6 ENDMDL MODEL 7 ENDMDL MODEL 8 ENDMDL MODEL 9 ENDMDL MODEL 10 ENDMDL MODEL 11 ENDMDL MODEL 12 ENDMDL MODEL 13 ENDMDL MODEL 14 ENDMDL MODEL 15 ENDMDL MODEL 16 ENDMDL MODEL 17 ENDMDL MODEL 18 ENDMDL MODEL 19 ENDMDL MODEL 20 ENDMDL MODEL 21 ENDMDL MODEL 22 ENDMDL MODEL 23 ENDMDL MODEL 24 ENDMDL MODEL 25 ENDMDL MODEL 26 ENDMDL MODEL 27 ENDMDL MODEL 28 ENDMDL MODEL 29 ENDMDL MODEL 30 ENDMDL MODEL 31 ENDMDL MODEL 32 ENDMDL MODEL 33 ENDMDL MODEL 34 ENDMDL MODEL 35 ENDMDL MODEL 36 ENDMDL MODEL 37 ENDMDL MODEL 38 ENDMDL MODEL 39 ENDMDL MODEL 40 ENDMDL MODEL 41 ENDMDL MODEL 42 ENDMDL MODEL 43 ENDMDL MODEL 44 ENDMDL MODEL 45 ENDMDL MODEL 46 ENDMDL MODEL 47 ENDMDL MODEL 48 ENDMDL MODEL 49 ENDMDL MODEL 50 ENDMDL MODEL 51 ENDMDL MODEL 52 ENDMDL MODEL 53 ENDMDL MODEL 54 ENDMDL MODEL 55 ENDMDL MODEL 56 ENDMDL MODEL 57 ENDMDL MODEL 58 ENDMDL MODEL 59 ENDMDL MODEL 60 ENDMDL MODEL 61 ENDMDL MODEL 62 ENDMDL MODEL 63 ENDMDL MODEL 64 ENDMDL MODEL 65 ENDMDL MODEL 66 ENDMDL MODEL 67 ENDMDL MODEL 68 ENDMDL MODEL 69 ENDMDL MODEL 70 ENDMDL MODEL 71 ENDMDL MODEL 72 ENDMDL MODEL 73 ENDMDL MODEL 74 ENDMDL MODEL 75 ENDMDL MODEL 76 ENDMDL MODEL 77 ENDMDL MODEL 78 ENDMDL MODEL 79 ENDMDL MODEL 80 ENDMDL MASTER 79 0 0 0 0 0 0 6 40 1 0 1 END